Affordable Access

109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a potential agent for targeted tumor therapy.

Authors
  • Das, Tapas
  • Chakraborty, Sudipta
  • Sarma, H D
  • Banerjee, Sharmila
Type
Published Article
Journal
Current radiopharmaceuticals
Publication Date
Oct 01, 2012
Volume
5
Issue
4
Pages
340–347
Identifiers
PMID: 22935057
Source
Medline
License
Unknown

Abstract

The complex exhibited good uptake and retention in the tumor along with encouraging target to non-target ratio. Preliminary biological studies indicated the promising attributes of the agent towards its use for targeted radiotherapy.

Report this publication

Statistics

Seen <100 times